This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
United States, Bethesda
MidCap Financial was established in 2008, and is a well known Corporate Investor. The fund is located in United States, North America. The primary office of this Corporate Investor is located in Bethesda.
Deals in the range of 50 - 100 millions dollars are most common for this fund. In comparison with other funds, MidCap Financial makes 30 percentage points more than the average number of lead investments. The fund generally invests in 2-6 deals every year. The highest number of exits from this fund were in 2014. In 2018, the fund's activity was at its peak. In addition, the fund was active in 2019. In terms of the fund's performance, this Corporate Investor has 21 percentage points more exits when compared to other organizations.
The usual method for the fund is to invest in rounds with 2 other investors. Along with MidCap Financial, start-ups are often financed by New Leaf Venture Partners, Wellington Partners, Triathlon Medical Venture Partners as well as 23 other investors. Other VCs who often invest in the same rounds are Silicon Valley Bank, Oxford Finance LLC, WuXi NextCODE. The investors in the following rounds are usually Foresite Capital, CRG L.P., WuXi NextCODE.
Also, a start-up has to be aged 11-15 years to expect investment from this fund. The country of its foundation and the country of its most frequent investments coincides - United States. Besides this, the fund also invested in 1 other country. We can highlight the most popular investment areas for this fund, such as Pharmaceutical, Medical. In addition, there are 14 more industries where it has achieved success. The fund has no an exact preference in the amount of founders of companies in its portfolio. If the applying start-up has 4 or 5+ founders, it is very unlikely that funding will be awarded. Intarcia Therapeutics, Spectranetics, DNAnexus are amongst the various portfolio companies of this fund.
Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]
Domain name: midcapfinancial.com; User name format in descending order of probability: first_initial last, first last, last first_initial, first, first last_initial
Group Appearance [how often fund is operating separately from groups with shared interest]
100.0% of cases
Investments per Year [average amount of rounds in which fund participates each year]
Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]
Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]
Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]
0.55 out of 1
Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]
Number of Minotaurs [amount of portfolio companies, which raised more then $1B in total]
Funds Investing in Previous
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.